05.04.2024 15:09:36

EQS-News: MEDICLIN buys Reha-Klinik am Sendesaal

EQS-News: MediClin AG / Key word(s): Expansion/Contract
MEDICLIN buys Reha-Klinik am Sendesaal

05.04.2024 / 15:09 CET/CEST
The issuer is solely responsible for the content of this announcement.


MEDICLIN buys Reha-Klinik am Sendesaal
The purchase agreement for the rehabilitation clinic in Bremen was signed today

Offenburg, 5 April 2024 - As of today, it's official: MEDICLIN is buying the Reha-Klinik am Sendesaal, which previously belonged to the Specht Group. The purchase agreement was signed this morning in Bremen.

"We warmly welcome the employees of the Reha-Klinik am Sendesaal", says Dr Joachim Ramming, CEO of MEDICLIN. "Rehabilitation is our core competence and we look forward to shaping the rehabilitation of the future together with the employees in Bremen!" The existing employment relationships are to be retained unchanged. A transfer of operations is planned for the second quarter.

Thomas Piefke, COO at MEDICLIN and responsible for the Rehab division, emphasises: "As part of our rehab strategy, we are in the process of expanding our structures in the ambulatory and - where appropriate - stationary areas. The Reha-Klinik am Sendesaal is a very good fit for our Group, both with its specialised areas and its mix of stationary and ambulatory services."

In future, the clinic will be managed by Holger Kammann, who is also Regional Managing Director and Head of the MEDICLIN Hedon Clinic in Lingen. "I'm looking forward to getting to know the staff at the Reha-Klinik am Sendesaal in the coming weeks and months and to travelling the path ahead together," says Kammann.

About the Rehabilitation Clinic at the Sendesaal
The Reha-Klinik am Sendesaal is an interdisciplinary clinic for inpatient and outpatient rehabilitation with the indications cardiology, orthopaedics and geriatrics. With 174 inpatient beds and up to 70 outpatient places, it covers a cross-indication rehabilitation spectrum.

For further information:

MEDICLIN Aktiengesellschaft
Okenstrasse 27
77652 Offenburg

Investor Relations
Ender Gülcan
Phone: 0781/488-326
Fax: 0781/488-184
ender.guelcan@mediclin.de
Public Relations
Dr Janina Lossen
Phone: 0781/488-180
janina.lossen@mediclin.de

www.mediclin.de

About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510)
MEDICLIN includes 32 clinics, six care facilities and ten medical care centers. The Group has around 8,300 beds/care places and employs around 10,000 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual needs and personal needs.

MEDICLIN ─ a company of the Asklepios Group
 


05.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MEDICLIN AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail: ender.guelcan@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1874595

 
End of News EQS News Service

1874595  05.04.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1874595&application_name=news&site_id=smarthouse

Analysen zu MediClin AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

MediClin AG 2,30 -0,86% MediClin AG